HEADER TRANSFERASE 20-JAN-17 5MWX TITLE GALECTIN-1 IN COMPLEX WITH LIGAND JB60 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GAL-1,14 KDA LAMININ-BINDING PROTEIN,HLBP14,14 KDA LECTIN, COMPND 5 BETA-GALACTOSIDE-BINDING LECTIN L-14-I,GALAPTIN,HBL,HPL,LACTOSE- COMPND 6 BINDING LECTIN 1,LECTIN GALACTOSIDE-BINDING SOLUBLE 1,PUTATIVE MAPK- COMPND 7 ACTIVATING PROTEIN PM12,S-LAC LECTIN 1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SUCROSE PHOSPHORYLASE, BISP, BIFIDOBACTERIUM, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.GRIMM,J.BECHOLD REVDAT 2 16-OCT-19 5MWX 1 REMARK REVDAT 1 28-FEB-18 5MWX 0 JRNL AUTH C.GRIMM,J.BECHOLD JRNL TITL GALECTIN-1 IN COMPLEX WITH LIGAND JB60 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2443 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.32 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 71171 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 3540 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.3387 - 3.7710 1.00 2932 170 0.1728 0.2063 REMARK 3 2 3.7710 - 2.9935 1.00 2805 144 0.1604 0.1998 REMARK 3 3 2.9935 - 2.6152 1.00 2766 150 0.1644 0.1900 REMARK 3 4 2.6152 - 2.3761 1.00 2745 153 0.1551 0.1983 REMARK 3 5 2.3761 - 2.2058 1.00 2740 154 0.1363 0.1459 REMARK 3 6 2.2058 - 2.0758 1.00 2701 148 0.1329 0.1925 REMARK 3 7 2.0758 - 1.9718 1.00 2732 150 0.1265 0.1548 REMARK 3 8 1.9718 - 1.8860 1.00 2738 123 0.1298 0.1528 REMARK 3 9 1.8860 - 1.8134 1.00 2738 124 0.1386 0.1902 REMARK 3 10 1.8134 - 1.7508 1.00 2754 117 0.1477 0.1996 REMARK 3 11 1.7508 - 1.6960 1.00 2704 135 0.1605 0.1892 REMARK 3 12 1.6960 - 1.6476 1.00 2707 146 0.1547 0.2226 REMARK 3 13 1.6476 - 1.6042 1.00 2666 144 0.1570 0.2324 REMARK 3 14 1.6042 - 1.5650 1.00 2708 142 0.1567 0.1896 REMARK 3 15 1.5650 - 1.5295 0.99 2654 160 0.1648 0.2293 REMARK 3 16 1.5295 - 1.4969 1.00 2695 124 0.1978 0.2294 REMARK 3 17 1.4969 - 1.4670 1.00 2712 136 0.2376 0.2799 REMARK 3 18 1.4670 - 1.4393 1.00 2651 153 0.2493 0.2908 REMARK 3 19 1.4393 - 1.4136 1.00 2695 137 0.2726 0.3389 REMARK 3 20 1.4136 - 1.3896 1.00 2670 131 0.2826 0.3044 REMARK 3 21 1.3896 - 1.3672 0.99 2701 139 0.3032 0.3281 REMARK 3 22 1.3672 - 1.3462 0.99 2657 153 0.3171 0.3580 REMARK 3 23 1.3462 - 1.3264 0.99 2616 156 0.3431 0.3610 REMARK 3 24 1.3264 - 1.3077 0.97 2591 141 0.3587 0.4045 REMARK 3 25 1.3077 - 1.2900 0.94 2553 110 0.3743 0.3413 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.023 2353 REMARK 3 ANGLE : 1.653 3204 REMARK 3 CHIRALITY : 0.116 350 REMARK 3 PLANARITY : 0.011 423 REMARK 3 DIHEDRAL : 22.870 967 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MWX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1200003149. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97242 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71546 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.290 REMARK 200 RESOLUTION RANGE LOW (A) : 40.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M AMMONIUM SULFATE, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.63000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.62500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.12500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.62500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.63000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.12500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 393 O HOH B 398 1.86 REMARK 500 O ASP A 134 O HOH A 301 2.03 REMARK 500 O HOH B 315 O HOH B 341 2.08 REMARK 500 OE1 GLN B 93 O HOH B 301 2.09 REMARK 500 O HOH B 335 O HOH B 374 2.09 REMARK 500 O HOH A 366 O HOH A 389 2.12 REMARK 500 NAE WYD A 202 O HOH A 302 2.16 REMARK 500 OE2 GLU A 22 O HOH A 303 2.18 REMARK 500 OE2 GLU B 105 O HOH B 302 2.18 REMARK 500 O HOH B 347 O HOH B 385 2.19 REMARK 500 O HOH B 302 O HOH B 397 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HH12 ARG A 20 OD2 ASP A 26 4555 1.47 REMARK 500 O HOH A 378 O HOH B 367 1565 1.99 REMARK 500 OE1 GLN A 93 CAN WYD B 202 3655 2.19 REMARK 500 O HOH B 335 O HOH B 349 4445 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 71 CB GLU A 71 CG -0.116 REMARK 500 GLU A 74 CG GLU A 74 CD 0.096 REMARK 500 VAL A 76 CB VAL A 76 CG2 -0.140 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 73 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 82.75 -163.12 REMARK 500 PHE A 77 78.38 -152.04 REMARK 500 PRO A 78 50.88 -91.36 REMARK 500 ASP A 125 54.82 -92.88 REMARK 500 PRO B 78 48.61 -94.24 REMARK 500 ASP B 125 47.45 -89.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WYD A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WYD B 202 DBREF 5MWX A 2 134 UNP P09382 LEG1_HUMAN 3 135 DBREF 5MWX B 2 134 UNP P09382 LEG1_HUMAN 3 135 SEQRES 1 A 133 CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO GLY SEQRES 2 A 133 GLU CME LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP ALA SEQRES 3 A 133 LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN ASN SEQRES 4 A 133 LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS GLY SEQRES 5 A 133 ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY GLY SEQRES 6 A 133 ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO PHE SEQRES 7 A 133 GLN PRO GLY SER VAL ALA GLU VAL CME ILE THR PHE ASP SEQRES 8 A 133 GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR GLU SEQRES 9 A 133 PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE ASN SEQRES 10 A 133 TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME VAL SEQRES 11 A 133 ALA PHE ASP SEQRES 1 B 133 CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO GLY SEQRES 2 B 133 GLU CME LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP ALA SEQRES 3 B 133 LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN ASN SEQRES 4 B 133 LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS GLY SEQRES 5 B 133 ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY GLY SEQRES 6 B 133 ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO PHE SEQRES 7 B 133 GLN PRO GLY SER VAL ALA GLU VAL CME ILE THR PHE ASP SEQRES 8 B 133 GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR GLU SEQRES 9 B 133 PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE ASN SEQRES 10 B 133 TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME VAL SEQRES 11 B 133 ALA PHE ASP MODRES 5MWX CME A 16 CYS MODIFIED RESIDUE MODRES 5MWX CME A 88 CYS MODIFIED RESIDUE MODRES 5MWX CME A 130 CYS MODIFIED RESIDUE MODRES 5MWX CME B 16 CYS MODIFIED RESIDUE MODRES 5MWX CME B 88 CYS MODIFIED RESIDUE MODRES 5MWX CME B 130 CYS MODIFIED RESIDUE HET CME A 16 19 HET CME A 88 19 HET CME A 130 19 HET CME B 16 19 HET CME B 88 19 HET CME B 130 19 HET BME A 201 8 HET WYD A 202 46 HET SO4 B 201 5 HET WYD B 202 46 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM BME BETA-MERCAPTOETHANOL HETNAM WYD ~{N}-[(2~{R},3~{R},4~{R},5~{S},6~{R})-5-[(2~{S},3~{R}, HETNAM 2 WYD 4~{S},5~{S},6~{R})-4-[[1-[[3-(3-AZANYLPROP-1-YNYL) HETNAM 3 WYD PHENYL]METHYL]-1,2,3-TRIAZOL-4-YL]METHOXY]-6- HETNAM 4 WYD (HYDROXYMETHYL)-3,5-BIS(OXIDANYL)OXAN-2-YL]OXY-6- HETNAM 5 WYD (HYDROXYMETHYL)-4-OXIDANYL-2-PROPOXY-OXAN-3- HETNAM 6 WYD YL]ETHANAMIDE HETNAM SO4 SULFATE ION FORMUL 1 CME 6(C5 H11 N O3 S2) FORMUL 3 BME C2 H6 O S FORMUL 4 WYD 2(C30 H43 N5 O11) FORMUL 5 SO4 O4 S 2- FORMUL 7 HOH *191(H2 O) HELIX 1 AA1 PRO B 101 GLY B 103 5 3 SHEET 1 AA112 ALA A 67 TRP A 68 0 SHEET 2 AA112 ASP A 54 ASP A 64 -1 N ASP A 64 O ALA A 67 SHEET 3 AA112 ASN A 40 ALA A 51 -1 N ARG A 48 O THR A 57 SHEET 4 AA112 PHE A 30 ASP A 37 -1 N LEU A 32 O PHE A 45 SHEET 5 AA112 ILE A 117 GLY A 124 -1 O ASP A 123 N VAL A 31 SHEET 6 AA112 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 AA112 VAL B 5 LEU B 11 -1 O SER B 7 N VAL A 5 SHEET 8 AA112 ILE B 117 GLY B 124 -1 O MET B 120 N ALA B 6 SHEET 9 AA112 PHE B 30 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 AA112 ASN B 40 ALA B 51 -1 O PHE B 45 N LEU B 32 SHEET 11 AA112 ASP B 54 ASP B 64 -1 O THR B 57 N ARG B 48 SHEET 12 AA112 ALA B 67 TRP B 68 -1 O ALA B 67 N ASP B 64 SHEET 1 AA212 GLN A 72 ARG A 73 0 SHEET 2 AA212 ASP A 54 ASP A 64 -1 N CYS A 60 O GLN A 72 SHEET 3 AA212 ASN A 40 ALA A 51 -1 N ARG A 48 O THR A 57 SHEET 4 AA212 PHE A 30 ASP A 37 -1 N LEU A 32 O PHE A 45 SHEET 5 AA212 ILE A 117 GLY A 124 -1 O ASP A 123 N VAL A 31 SHEET 6 AA212 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 AA212 VAL B 5 LEU B 11 -1 O SER B 7 N VAL A 5 SHEET 8 AA212 ILE B 117 GLY B 124 -1 O MET B 120 N ALA B 6 SHEET 9 AA212 PHE B 30 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 AA212 ASN B 40 ALA B 51 -1 O PHE B 45 N LEU B 32 SHEET 11 AA212 ASP B 54 ASP B 64 -1 O THR B 57 N ARG B 48 SHEET 12 AA212 GLN B 72 ARG B 73 -1 O GLN B 72 N CYS B 60 SHEET 1 AA310 GLU A 105 PRO A 109 0 SHEET 2 AA310 ASN A 95 LYS A 99 -1 N LEU A 96 O PHE A 108 SHEET 3 AA310 SER A 83 PHE A 91 -1 N THR A 90 O THR A 97 SHEET 4 AA310 LEU A 17 VAL A 23 -1 N LEU A 17 O ILE A 89 SHEET 5 AA310 PHE A 126 PHE A 133 -1 O LYS A 129 N ARG A 20 SHEET 6 AA310 PHE B 126 ASP B 134 -1 O PHE B 133 N LYS A 129 SHEET 7 AA310 CME B 16 VAL B 23 -1 N GLU B 22 O LYS B 127 SHEET 8 AA310 SER B 83 PHE B 91 -1 O SER B 83 N VAL B 23 SHEET 9 AA310 ASN B 95 LYS B 99 -1 O LYS B 99 N CME B 88 SHEET 10 AA310 GLU B 105 PRO B 109 -1 O PHE B 108 N LEU B 96 LINK C GLU A 15 N CME A 16 1555 1555 1.33 LINK C CME A 16 N LEU A 17 1555 1555 1.33 LINK C VAL A 87 N CME A 88 1555 1555 1.32 LINK C CME A 88 N ILE A 89 1555 1555 1.32 LINK C LYS A 129 N CME A 130 1555 1555 1.31 LINK C CME A 130 N AVAL A 131 1555 1555 1.34 LINK C CME A 130 N BVAL A 131 1555 1555 1.33 LINK C GLU B 15 N CME B 16 1555 1555 1.34 LINK C CME B 16 N LEU B 17 1555 1555 1.31 LINK C VAL B 87 N CME B 88 1555 1555 1.33 LINK C CME B 88 N ILE B 89 1555 1555 1.31 LINK C LYS B 129 N CME B 130 1555 1555 1.32 LINK C CME B 130 N AVAL B 131 1555 1555 1.31 LINK C CME B 130 N BVAL B 131 1555 1555 1.32 LINK OE1 GLN A 93 NAA WYD B 202 1555 3655 1.30 SITE 1 AC1 7 LYS A 36 LEU A 114 GLU A 115 ALA A 116 SITE 2 AC1 7 HOH A 341 HOH A 382 LYS B 28 SITE 1 AC2 14 SER A 29 HIS A 44 ASN A 46 ARG A 48 SITE 2 AC2 14 HIS A 52 ASN A 61 GLU A 71 ARG A 73 SITE 3 AC2 14 ASP A 123 GLY A 124 ASP A 125 HOH A 302 SITE 4 AC2 14 HOH A 349 THR B 70 SITE 1 AC3 9 PRO A 101 ASP A 102 ASN B 10 LYS B 12 SITE 2 AC3 9 HOH B 317 HOH B 318 HOH B 321 HOH B 332 SITE 3 AC3 9 HOH B 343 SITE 1 AC4 15 GLN A 72 GLN A 93 ASN A 113 HIS B 44 SITE 2 AC4 15 ASN B 46 ARG B 48 HIS B 52 ASN B 61 SITE 3 AC4 15 GLU B 71 ARG B 73 ASP B 123 GLY B 124 SITE 4 AC4 15 HOH B 303 HOH B 307 HOH B 367 CRYST1 43.260 58.250 111.250 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023116 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017167 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008989 0.00000